Cite
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study
MLA
MS Hematologie, et al. Impact of Etoposide and ASCT on Survival among Patients Aged <65 Years with Stage II to IV PTCL: A Population-Based Cohort Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432120231&authtype=sso&custid=ns315887.
APA
MS Hematologie, Cancer, Infection & Immunity, Regenerative Medicine and Stem Cells, Brink, M., Meeuwes, F. O., van der Poel, M. W. M., Kersten, M. J., Wondergem, M., Mutsaers, P. G. N. J., Böhmer, L. H., Woei-A-Jin, F. J. S. H., Visser, O., Oostvogels, R., Jansen, P. M., Plattel, W., Huls, G. A., Vermaat, J. S. P., & Nijland, M. (2022). Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Chicago
MS Hematologie, Cancer, Infection & Immunity, Regenerative Medicine and Stem Cells, Mirian Brink, Frederik O. Meeuwes, Marjolein W.M. van der Poel, et al. 2022. “Impact of Etoposide and ASCT on Survival among Patients Aged <65 Years with Stage II to IV PTCL: A Population-Based Cohort Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432120231&authtype=sso&custid=ns315887.